Pages that link to "Q58448979"
Jump to navigation
Jump to search
The following pages link to Glucagon-Like Peptide 1(7-36) Amide Stimulates Exocytosis in Human Pancreatic -Cells by Both Proximal and Distal Regulatory Steps in Stimulus-Secretion Coupling (Q58448979):
Displaying 50 items.
- A novel lipid-anchored A-kinase Anchoring Protein facilitates cAMP-responsive membrane events (Q24324609) (← links)
- Epac: A new cAMP-binding protein in support of glucagon-like peptide-1 receptor-mediated signal transduction in the pancreatic beta-cell (Q24619138) (← links)
- Mechanisms of action of glucagon-like peptide 1 in the pancreas (Q24683764) (← links)
- GLP-1 receptor activated insulin secretion from pancreatic β-cells: mechanism and glucose dependence (Q26858990) (← links)
- cAMP-dependent mobilization of intracellular Ca2+ stores by activation of ryanodine receptors in pancreatic beta-cells. A Ca2+ signaling system stimulated by the insulinotropic hormone glucagon-like peptide-1-(7-37) (Q27863652) (← links)
- Expression of cAMP-regulated guanine nucleotide exchange factors in pancreatic beta-cells (Q27863676) (← links)
- Type VIII adenylyl cyclase in rat beta cells: coincidence signal detector/generator for glucose and GLP-1. (Q27863774) (← links)
- cAMP sensor Epac as a determinant of ATP-sensitive potassium channel activity in human pancreatic beta cells and rat INS-1 cells (Q27863919) (← links)
- Role of the cAMP sensor Epac as a determinant of KATP channel ATP sensitivity in human pancreatic beta-cells and rat INS-1 cells (Q27865206) (← links)
- Unifying concepts in stimulus-secretion coupling in endocrine cells and some implications for therapeutics (Q28258117) (← links)
- cAMP-regulated guanine nucleotide exchange factor II (Epac2) mediates Ca2+-induced Ca2+ release in INS-1 pancreatic beta-cells (Q28361658) (← links)
- Emerging role of dipeptidyl peptidase-4 inhibitors in the management of type 2 diabetes (Q28762629) (← links)
- Glucose-dependent insulinotropic polypeptide signaling in pancreatic β-cells and adipocytes (Q33609770) (← links)
- Is the diminished incretin effect in type 2 diabetes just an epi-phenomenon of impaired beta-cell function? (Q33803409) (← links)
- New insights concerning the glucose-dependent insulin secretagogue action of glucagon-like peptide-1 in pancreatic beta-cells (Q34037472) (← links)
- Glucagon-like peptide 1(GLP-1) in biology and pathology (Q34401791) (← links)
- Ionic mechanisms in pancreatic β cell signaling (Q34430333) (← links)
- Epac2-dependent rap1 activation and the control of islet insulin secretion by glucagon-like peptide-1. (Q34436421) (← links)
- Subthreshold α₂-adrenergic activation counteracts glucagon-like peptide-1 potentiation of glucose-stimulated insulin secretion (Q34495341) (← links)
- The role of gut hormones in glucose homeostasis (Q35251016) (← links)
- Glucagon-like peptide 1 inhibits the sirtuin deacetylase SirT1 to stimulate pancreatic β-cell mass expansion. (Q35561114) (← links)
- The isolated pancreatic islet as a micro-organ and its transplantation to cure diabetes: celebrating the legacy of Paul Lacy (Q35878665) (← links)
- Reduced insulin exocytosis in human pancreatic β-cells with gene variants linked to type 2 diabetes (Q36047543) (← links)
- Glucagon-like peptide 1 (GLP-1) and metabolic diseases (Q36309183) (← links)
- The incretin hormone glucagon-like peptide 1 increases mitral cell excitability by decreasing conductance of a voltage-dependent potassium channel (Q36897100) (← links)
- Targeting beta-cell mass in type 2 diabetes: promise and limitations of new drugs based on incretins (Q37091579) (← links)
- Novel aspects of the molecular mechanisms controlling insulin secretion (Q37176911) (← links)
- Cav1.2 and Cav1.3 are differentially coupled to glucagon-like peptide-1 potentiation of glucose-stimulated insulin secretion in the pancreatic beta-cell line INS-1. (Q37416435) (← links)
- K(ATP) channelopathies in the pancreas (Q37634376) (← links)
- Review of approved pioglitazone combinations for type 2 diabetes (Q37884618) (← links)
- Molecular physiology of glucagon-like peptide-1 insulin secretagogue action in pancreatic β cells. (Q37904176) (← links)
- Modulation of the pancreatic islet-stress axis as a novel potential therapeutic target in diabetes mellitus (Q38190197) (← links)
- Comparative evaluation of incretin-based antidiabetic medications and alternative therapies to be added to metformin in the case of monotherapy failure (Q38213037) (← links)
- G protein-coupled receptors in energy homeostasis (Q38223619) (← links)
- Expression of glucagon-like Peptide-1 receptor in papillary thyroid carcinoma and its clinicopathologic significance (Q38307641) (← links)
- PREB regulates transcription of pancreatic glucokinase in response to glucose and cAMP. (Q38356120) (← links)
- Glucagon-like peptide-1 drives energy metabolism on the synaptic highway (Q38868456) (← links)
- A role of PLC/PKC-dependent pathway in GLP-1-stimulated insulin secretion (Q39015682) (← links)
- Amplification of exocytosis by Ca2+-induced Ca2+ release in INS-1 pancreatic beta cells (Q40679793) (← links)
- Cooperative enhancement of insulinotropic action of GLP-1 by acetylcholine uncovers paradoxical inhibitory effect of beta cell muscarinic receptor activation on adenylate cyclase activity. (Q40680513) (← links)
- A Novel GLP1 Receptor Interacting Protein ATP6ap2 Regulates Insulin Secretion in Pancreatic Beta Cells (Q41070874) (← links)
- Allosteric Optical Control of a Class B G-Protein-Coupled Receptor. (Q41143099) (← links)
- cAMP-secretion coupling is impaired in diabetic GK/Par rat β-cells: a defect counteracted by GLP-1. (Q42491408) (← links)
- Immaturity of insulin secretion by pancreatic islets isolated from one human neonate. (Q42510813) (← links)
- Regulation of glucose kinetics during exercise by the glucagon-like peptide-1 receptor (Q42511192) (← links)
- A cAMP and Ca2+ coincidence detector in support of Ca2+-induced Ca2+ release in mouse pancreatic beta cells (Q43239185) (← links)
- The insulinotropic mechanism of the novel hypoglycaemic agent JTT-608: direct enhancement of Ca(2+) efficacy and increase of Ca(2+) influx by phosphodiesterase inhibition (Q43262866) (← links)
- Renoprotection in Type 2 diabetes: blockade of the renin-angiotensin system with angiotensin II receptor blockers (Q43907273) (← links)
- Age-dependent human β cell proliferation induced by glucagon-like peptide 1 and calcineurin signaling (Q44899742) (← links)
- Pancreatic β-Cell Electrical Activity and Insulin Secretion: Of Mice and Men. (Q47322426) (← links)